Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,483
archived clinical trials in
Influenza

Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza Infection
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of CR8020 and CR6261 in Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated:  1/8/2014
Clinical Research Facility
mi
from
Cleveland, OH
Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza Infection
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of CR8020 and CR6261 in Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated: 1/8/2014
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza Infection
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of CR8020 and CR6261 in Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated:  1/8/2014
Clinical Research Facility
mi
from
Dayton, OH
Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza Infection
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of CR8020 and CR6261 in Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated: 1/8/2014
Clinical Research Facility
mi
from
Dayton, OH
Click here to add this to my saved trials
Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza Infection
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of CR8020 and CR6261 in Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated:  1/8/2014
Clinical Research Facility
mi
from
Hershey, PA
Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza Infection
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of CR8020 and CR6261 in Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated: 1/8/2014
Clinical Research Facility
mi
from
Hershey, PA
Click here to add this to my saved trials
Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza Infection
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of CR8020 and CR6261 in Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated:  1/8/2014
Clinical Research Facility
mi
from
Wilkes Barre, PA
Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza Infection
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of CR8020 and CR6261 in Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated: 1/8/2014
Clinical Research Facility
mi
from
Wilkes Barre, PA
Click here to add this to my saved trials
Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza Infection
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of CR8020 and CR6261 in Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated:  1/8/2014
Clinical Research Facility
mi
from
Nashville, TN
Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza Infection
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of CR8020 and CR6261 in Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated: 1/8/2014
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza Infection
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of CR8020 and CR6261 in Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated:  1/8/2014
Clinical Research Facility
mi
from
Houston, TX
Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza Infection
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of CR8020 and CR6261 in Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated: 1/8/2014
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza Infection
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of CR8020 and CR6261 in Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated:  1/8/2014
Clinical Research Facility
mi
from
Salt Lake City, UT
Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza Infection
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of CR8020 and CR6261 in Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated: 1/8/2014
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza Infection
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of CR8020 and CR6261 in Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated:  1/8/2014
Clinical Research Facility
mi
from
Seattle, WA
Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza Infection
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of CR8020 and CR6261 in Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated: 1/8/2014
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Influenza Diagnosis, Treatment and Surveillance With Xpert Flu
Influenza Diagnosis, Treatment and Surveillance With Xpert Flu
Status: Enrolling
Updated:  1/9/2014
Maricopa Medical Center
mi
from
Pheonix, AZ
Influenza Diagnosis, Treatment and Surveillance With Xpert Flu
Influenza Diagnosis, Treatment and Surveillance With Xpert Flu
Status: Enrolling
Updated: 1/9/2014
Maricopa Medical Center
mi
from
Pheonix, AZ
Click here to add this to my saved trials
Influenza Diagnosis, Treatment and Surveillance With Xpert Flu
Influenza Diagnosis, Treatment and Surveillance With Xpert Flu
Status: Enrolling
Updated:  1/9/2014
Olive View - UCLA Medical Center
mi
from
Sylmar, CA
Influenza Diagnosis, Treatment and Surveillance With Xpert Flu
Influenza Diagnosis, Treatment and Surveillance With Xpert Flu
Status: Enrolling
Updated: 1/9/2014
Olive View - UCLA Medical Center
mi
from
Sylmar, CA
Click here to add this to my saved trials
Influenza Diagnosis, Treatment and Surveillance With Xpert Flu
Influenza Diagnosis, Treatment and Surveillance With Xpert Flu
Status: Enrolling
Updated:  1/9/2014
Johns Hopkins Hosp
mi
from
Baltimore, MD
Influenza Diagnosis, Treatment and Surveillance With Xpert Flu
Influenza Diagnosis, Treatment and Surveillance With Xpert Flu
Status: Enrolling
Updated: 1/9/2014
Johns Hopkins Hosp
mi
from
Baltimore, MD
Click here to add this to my saved trials
Influenza Diagnosis, Treatment and Surveillance With Xpert Flu
Influenza Diagnosis, Treatment and Surveillance With Xpert Flu
Status: Enrolling
Updated:  1/9/2014
Truman Medical Center
mi
from
Kansas City, MO
Influenza Diagnosis, Treatment and Surveillance With Xpert Flu
Influenza Diagnosis, Treatment and Surveillance With Xpert Flu
Status: Enrolling
Updated: 1/9/2014
Truman Medical Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
Detection of Influenza A, Influenza B, and RSV Using the Liat Analyzer
Multi-Center Study of In Vitro Diagnostic Devices for the Detection of Influenza A, Influenza B, and RSV
Status: Enrolling
Updated:  2/19/2014
Pediatrics by the Sea
mi
from
Delray Beach, FL
Detection of Influenza A, Influenza B, and RSV Using the Liat Analyzer
Multi-Center Study of In Vitro Diagnostic Devices for the Detection of Influenza A, Influenza B, and RSV
Status: Enrolling
Updated: 2/19/2014
Pediatrics by the Sea
mi
from
Delray Beach, FL
Click here to add this to my saved trials
Detection of Influenza A, Influenza B, and RSV Using the Liat Analyzer
Multi-Center Study of In Vitro Diagnostic Devices for the Detection of Influenza A, Influenza B, and RSV
Status: Enrolling
Updated:  2/19/2014
Meridian Clinical Research, LLC
mi
from
Savannah, GA
Detection of Influenza A, Influenza B, and RSV Using the Liat Analyzer
Multi-Center Study of In Vitro Diagnostic Devices for the Detection of Influenza A, Influenza B, and RSV
Status: Enrolling
Updated: 2/19/2014
Meridian Clinical Research, LLC
mi
from
Savannah, GA
Click here to add this to my saved trials
Detection of Influenza A, Influenza B, and RSV Using the Liat Analyzer
Multi-Center Study of In Vitro Diagnostic Devices for the Detection of Influenza A, Influenza B, and RSV
Status: Enrolling
Updated:  2/19/2014
Northpoint Pediatrics
mi
from
Indianapolis, IN
Detection of Influenza A, Influenza B, and RSV Using the Liat Analyzer
Multi-Center Study of In Vitro Diagnostic Devices for the Detection of Influenza A, Influenza B, and RSV
Status: Enrolling
Updated: 2/19/2014
Northpoint Pediatrics
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Detection of Influenza A, Influenza B, and RSV Using the Liat Analyzer
Multi-Center Study of In Vitro Diagnostic Devices for the Detection of Influenza A, Influenza B, and RSV
Status: Enrolling
Updated:  2/19/2014
Meridian Clinical Research
mi
from
Bellevue, NE
Detection of Influenza A, Influenza B, and RSV Using the Liat Analyzer
Multi-Center Study of In Vitro Diagnostic Devices for the Detection of Influenza A, Influenza B, and RSV
Status: Enrolling
Updated: 2/19/2014
Meridian Clinical Research
mi
from
Bellevue, NE
Click here to add this to my saved trials
Detection of Influenza A, Influenza B, and RSV Using the Liat Analyzer
Multi-Center Study of In Vitro Diagnostic Devices for the Detection of Influenza A, Influenza B, and RSV
Status: Enrolling
Updated:  2/19/2014
Accurate Clinical Research
mi
from
Houston, TX
Detection of Influenza A, Influenza B, and RSV Using the Liat Analyzer
Multi-Center Study of In Vitro Diagnostic Devices for the Detection of Influenza A, Influenza B, and RSV
Status: Enrolling
Updated: 2/19/2014
Accurate Clinical Research
mi
from
Houston, TX
Click here to add this to my saved trials
Detection of Influenza A, Influenza B, and RSV Using the Liat Analyzer
Multi-Center Study of In Vitro Diagnostic Devices for the Detection of Influenza A, Influenza B, and RSV
Status: Enrolling
Updated:  2/19/2014
Plano Pediatrics
mi
from
Plano, TX
Detection of Influenza A, Influenza B, and RSV Using the Liat Analyzer
Multi-Center Study of In Vitro Diagnostic Devices for the Detection of Influenza A, Influenza B, and RSV
Status: Enrolling
Updated: 2/19/2014
Plano Pediatrics
mi
from
Plano, TX
Click here to add this to my saved trials
Detection of Influenza A, Influenza B, and RSV Using the Liat Analyzer
Multi-Center Study of In Vitro Diagnostic Devices for the Detection of Influenza A, Influenza B, and RSV
Status: Enrolling
Updated:  2/19/2014
Advanced Pediatrics
mi
from
Vienna, VA
Detection of Influenza A, Influenza B, and RSV Using the Liat Analyzer
Multi-Center Study of In Vitro Diagnostic Devices for the Detection of Influenza A, Influenza B, and RSV
Status: Enrolling
Updated: 2/19/2014
Advanced Pediatrics
mi
from
Vienna, VA
Click here to add this to my saved trials
Phase 1 Safety Study of Recombinant Influenza Vaccine for Prevention
Phase 1 Study of the Safety and Immunogenicity of VAX2012Q: A Quadrivalent Influenza Vaccine in Healthy Adults Age 18-40 Years
Status: Enrolling
Updated:  3/29/2014
Johnson County Clin-Trials
mi
from
Lenexa, KA
Phase 1 Safety Study of Recombinant Influenza Vaccine for Prevention
Phase 1 Study of the Safety and Immunogenicity of VAX2012Q: A Quadrivalent Influenza Vaccine in Healthy Adults Age 18-40 Years
Status: Enrolling
Updated: 3/29/2014
Johnson County Clin-Trials
mi
from
Lenexa, KA
Click here to add this to my saved trials
Phase 1 Safety Study of Recombinant Influenza Vaccine for Prevention
Phase 1 Study of the Safety and Immunogenicity of VAX2012Q: A Quadrivalent Influenza Vaccine in Healthy Adults Age 18-40 Years
Status: Enrolling
Updated:  3/29/2014
Rochester Clinical Research Inc.
mi
from
Rochester, NY
Phase 1 Safety Study of Recombinant Influenza Vaccine for Prevention
Phase 1 Study of the Safety and Immunogenicity of VAX2012Q: A Quadrivalent Influenza Vaccine in Healthy Adults Age 18-40 Years
Status: Enrolling
Updated: 3/29/2014
Rochester Clinical Research Inc.
mi
from
Rochester, NY
Click here to add this to my saved trials
Phase 1 Safety Study of Recombinant Influenza Vaccine for Prevention
Phase 1 Study of the Safety and Immunogenicity of VAX2012Q: A Quadrivalent Influenza Vaccine in Healthy Adults Age 18-40 Years
Status: Enrolling
Updated:  3/29/2014
Coastal Carolina Research Center
mi
from
Mt. Pleasant, SC
Phase 1 Safety Study of Recombinant Influenza Vaccine for Prevention
Phase 1 Study of the Safety and Immunogenicity of VAX2012Q: A Quadrivalent Influenza Vaccine in Healthy Adults Age 18-40 Years
Status: Enrolling
Updated: 3/29/2014
Coastal Carolina Research Center
mi
from
Mt. Pleasant, SC
Click here to add this to my saved trials
Phase 1 Safety Study of Recombinant Influenza Vaccine for Prevention
Phase 1 Study of the Safety and Immunogenicity of VAX2012Q: A Quadrivalent Influenza Vaccine in Healthy Adults Age 18-40 Years
Status: Enrolling
Updated:  3/29/2014
Tekton Research
mi
from
Austin, TX
Phase 1 Safety Study of Recombinant Influenza Vaccine for Prevention
Phase 1 Study of the Safety and Immunogenicity of VAX2012Q: A Quadrivalent Influenza Vaccine in Healthy Adults Age 18-40 Years
Status: Enrolling
Updated: 3/29/2014
Tekton Research
mi
from
Austin, TX
Click here to add this to my saved trials
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Status: Enrolling
Updated:  4/3/2014
University of California at San Diego
mi
from
San Diego, CA
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Status: Enrolling
Updated: 4/3/2014
University of California at San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Status: Enrolling
Updated:  4/3/2014
Denver Public Health
mi
from
Denver, CO
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Status: Enrolling
Updated: 4/3/2014
Denver Public Health
mi
from
Denver, CO
Click here to add this to my saved trials
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Status: Enrolling
Updated:  4/3/2014
George Washington University
mi
from
Washington,
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Status: Enrolling
Updated: 4/3/2014
George Washington University
mi
from
Washington,
Click here to add this to my saved trials
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Status: Enrolling
Updated:  4/3/2014
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Status: Enrolling
Updated: 4/3/2014
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Status: Enrolling
Updated:  4/3/2014
Henry Ford Hospital
mi
from
Detroit, MI
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Status: Enrolling
Updated: 4/3/2014
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Status: Enrolling
Updated:  4/3/2014
Mayo Clinic Rochester
mi
from
Rochester, MN
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Status: Enrolling
Updated: 4/3/2014
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Status: Enrolling
Updated:  4/3/2014
Cooper University Hospital
mi
from
Camden, NJ
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Status: Enrolling
Updated: 4/3/2014
Cooper University Hospital
mi
from
Camden, NJ
Click here to add this to my saved trials
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Status: Enrolling
Updated:  4/3/2014
Montefiore Medical Center
mi
from
Bronx, NY
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Status: Enrolling
Updated: 4/3/2014
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Status: Enrolling
Updated:  4/3/2014
The Ohio State University, Wexner Medical Center
mi
from
Columbus, OH
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Status: Enrolling
Updated: 4/3/2014
The Ohio State University, Wexner Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Status: Enrolling
Updated:  4/3/2014
Miami Valley Hospital
mi
from
Dayton, OH
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Status: Enrolling
Updated: 4/3/2014
Miami Valley Hospital
mi
from
Dayton, OH
Click here to add this to my saved trials
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Status: Enrolling
Updated:  4/3/2014
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Status: Enrolling
Updated: 4/3/2014
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Randomized, Age-stratified, Double Blind, Controlled Phase 3 Study Comparing a Vero Cell-derived Trivalent Seasonal Influenza Vaccine Made by the Modified Manufacturing Process With Vaccine Made by the Current Manufacturing Process and a Licensed Trivalent Influenza Vaccine in Healthy Adults Aged 18 Years and Older
Status: Enrolling
Updated:  6/27/2014
East Valley Family Physicians PLC
mi
from
Chandler, AZ
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Randomized, Age-stratified, Double Blind, Controlled Phase 3 Study Comparing a Vero Cell-derived Trivalent Seasonal Influenza Vaccine Made by the Modified Manufacturing Process With Vaccine Made by the Current Manufacturing Process and a Licensed Trivalent Influenza Vaccine in Healthy Adults Aged 18 Years and Older
Status: Enrolling
Updated: 6/27/2014
East Valley Family Physicians PLC
mi
from
Chandler, AZ
Click here to add this to my saved trials
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Randomized, Age-stratified, Double Blind, Controlled Phase 3 Study Comparing a Vero Cell-derived Trivalent Seasonal Influenza Vaccine Made by the Modified Manufacturing Process With Vaccine Made by the Current Manufacturing Process and a Licensed Trivalent Influenza Vaccine in Healthy Adults Aged 18 Years and Older
Status: Enrolling
Updated:  6/27/2014
California Research Foundation
mi
from
San Diego, CA
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Randomized, Age-stratified, Double Blind, Controlled Phase 3 Study Comparing a Vero Cell-derived Trivalent Seasonal Influenza Vaccine Made by the Modified Manufacturing Process With Vaccine Made by the Current Manufacturing Process and a Licensed Trivalent Influenza Vaccine in Healthy Adults Aged 18 Years and Older
Status: Enrolling
Updated: 6/27/2014
California Research Foundation
mi
from
San Diego, CA
Click here to add this to my saved trials
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Randomized, Age-stratified, Double Blind, Controlled Phase 3 Study Comparing a Vero Cell-derived Trivalent Seasonal Influenza Vaccine Made by the Modified Manufacturing Process With Vaccine Made by the Current Manufacturing Process and a Licensed Trivalent Influenza Vaccine in Healthy Adults Aged 18 Years and Older
Status: Enrolling
Updated:  6/27/2014
Benchmark Research San Francisco
mi
from
San Francisco, CA
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Randomized, Age-stratified, Double Blind, Controlled Phase 3 Study Comparing a Vero Cell-derived Trivalent Seasonal Influenza Vaccine Made by the Modified Manufacturing Process With Vaccine Made by the Current Manufacturing Process and a Licensed Trivalent Influenza Vaccine in Healthy Adults Aged 18 Years and Older
Status: Enrolling
Updated: 6/27/2014
Benchmark Research San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Randomized, Age-stratified, Double Blind, Controlled Phase 3 Study Comparing a Vero Cell-derived Trivalent Seasonal Influenza Vaccine Made by the Modified Manufacturing Process With Vaccine Made by the Current Manufacturing Process and a Licensed Trivalent Influenza Vaccine in Healthy Adults Aged 18 Years and Older
Status: Enrolling
Updated:  6/27/2014
Heartland Research Associates, LLC
mi
from
Wichita, KA
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Randomized, Age-stratified, Double Blind, Controlled Phase 3 Study Comparing a Vero Cell-derived Trivalent Seasonal Influenza Vaccine Made by the Modified Manufacturing Process With Vaccine Made by the Current Manufacturing Process and a Licensed Trivalent Influenza Vaccine in Healthy Adults Aged 18 Years and Older
Status: Enrolling
Updated: 6/27/2014
Heartland Research Associates, LLC
mi
from
Wichita, KA
Click here to add this to my saved trials
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Randomized, Age-stratified, Double Blind, Controlled Phase 3 Study Comparing a Vero Cell-derived Trivalent Seasonal Influenza Vaccine Made by the Modified Manufacturing Process With Vaccine Made by the Current Manufacturing Process and a Licensed Trivalent Influenza Vaccine in Healthy Adults Aged 18 Years and Older
Status: Enrolling
Updated:  6/27/2014
The Center for Pharmaceutical Research, P.C.
mi
from
Kansas City, MO
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Randomized, Age-stratified, Double Blind, Controlled Phase 3 Study Comparing a Vero Cell-derived Trivalent Seasonal Influenza Vaccine Made by the Modified Manufacturing Process With Vaccine Made by the Current Manufacturing Process and a Licensed Trivalent Influenza Vaccine in Healthy Adults Aged 18 Years and Older
Status: Enrolling
Updated: 6/27/2014
The Center for Pharmaceutical Research, P.C.
mi
from
Kansas City, MO
Click here to add this to my saved trials
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Randomized, Age-stratified, Double Blind, Controlled Phase 3 Study Comparing a Vero Cell-derived Trivalent Seasonal Influenza Vaccine Made by the Modified Manufacturing Process With Vaccine Made by the Current Manufacturing Process and a Licensed Trivalent Influenza Vaccine in Healthy Adults Aged 18 Years and Older
Status: Enrolling
Updated:  6/27/2014
Sundance Clinical Research, LLC
mi
from
St. Louis, MO
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Randomized, Age-stratified, Double Blind, Controlled Phase 3 Study Comparing a Vero Cell-derived Trivalent Seasonal Influenza Vaccine Made by the Modified Manufacturing Process With Vaccine Made by the Current Manufacturing Process and a Licensed Trivalent Influenza Vaccine in Healthy Adults Aged 18 Years and Older
Status: Enrolling
Updated: 6/27/2014
Sundance Clinical Research, LLC
mi
from
St. Louis, MO
Click here to add this to my saved trials
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Randomized, Age-stratified, Double Blind, Controlled Phase 3 Study Comparing a Vero Cell-derived Trivalent Seasonal Influenza Vaccine Made by the Modified Manufacturing Process With Vaccine Made by the Current Manufacturing Process and a Licensed Trivalent Influenza Vaccine in Healthy Adults Aged 18 Years and Older
Status: Enrolling
Updated:  6/27/2014
Rochester Clinical Research Inc.
mi
from
Rochester, NY
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Randomized, Age-stratified, Double Blind, Controlled Phase 3 Study Comparing a Vero Cell-derived Trivalent Seasonal Influenza Vaccine Made by the Modified Manufacturing Process With Vaccine Made by the Current Manufacturing Process and a Licensed Trivalent Influenza Vaccine in Healthy Adults Aged 18 Years and Older
Status: Enrolling
Updated: 6/27/2014
Rochester Clinical Research Inc.
mi
from
Rochester, NY
Click here to add this to my saved trials
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Randomized, Age-stratified, Double Blind, Controlled Phase 3 Study Comparing a Vero Cell-derived Trivalent Seasonal Influenza Vaccine Made by the Modified Manufacturing Process With Vaccine Made by the Current Manufacturing Process and a Licensed Trivalent Influenza Vaccine in Healthy Adults Aged 18 Years and Older
Status: Enrolling
Updated:  6/27/2014
PMG Research of Cary
mi
from
Cary, NC
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Randomized, Age-stratified, Double Blind, Controlled Phase 3 Study Comparing a Vero Cell-derived Trivalent Seasonal Influenza Vaccine Made by the Modified Manufacturing Process With Vaccine Made by the Current Manufacturing Process and a Licensed Trivalent Influenza Vaccine in Healthy Adults Aged 18 Years and Older
Status: Enrolling
Updated: 6/27/2014
PMG Research of Cary
mi
from
Cary, NC
Click here to add this to my saved trials
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Randomized, Age-stratified, Double Blind, Controlled Phase 3 Study Comparing a Vero Cell-derived Trivalent Seasonal Influenza Vaccine Made by the Modified Manufacturing Process With Vaccine Made by the Current Manufacturing Process and a Licensed Trivalent Influenza Vaccine in Healthy Adults Aged 18 Years and Older
Status: Enrolling
Updated:  6/27/2014
Rapid Medical Research, Inc.
mi
from
Cleveland, OH
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Randomized, Age-stratified, Double Blind, Controlled Phase 3 Study Comparing a Vero Cell-derived Trivalent Seasonal Influenza Vaccine Made by the Modified Manufacturing Process With Vaccine Made by the Current Manufacturing Process and a Licensed Trivalent Influenza Vaccine in Healthy Adults Aged 18 Years and Older
Status: Enrolling
Updated: 6/27/2014
Rapid Medical Research, Inc.
mi
from
Cleveland, OH
Click here to add this to my saved trials
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Randomized, Age-stratified, Double Blind, Controlled Phase 3 Study Comparing a Vero Cell-derived Trivalent Seasonal Influenza Vaccine Made by the Modified Manufacturing Process With Vaccine Made by the Current Manufacturing Process and a Licensed Trivalent Influenza Vaccine in Healthy Adults Aged 18 Years and Older
Status: Enrolling
Updated:  6/27/2014
Spartanburg Medical Research
mi
from
Spartanburg, SC
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Randomized, Age-stratified, Double Blind, Controlled Phase 3 Study Comparing a Vero Cell-derived Trivalent Seasonal Influenza Vaccine Made by the Modified Manufacturing Process With Vaccine Made by the Current Manufacturing Process and a Licensed Trivalent Influenza Vaccine in Healthy Adults Aged 18 Years and Older
Status: Enrolling
Updated: 6/27/2014
Spartanburg Medical Research
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Randomized, Age-stratified, Double Blind, Controlled Phase 3 Study Comparing a Vero Cell-derived Trivalent Seasonal Influenza Vaccine Made by the Modified Manufacturing Process With Vaccine Made by the Current Manufacturing Process and a Licensed Trivalent Influenza Vaccine in Healthy Adults Aged 18 Years and Older
Status: Enrolling
Updated:  6/27/2014
Benchmark Research, Austin
mi
from
Austin, TX
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Randomized, Age-stratified, Double Blind, Controlled Phase 3 Study Comparing a Vero Cell-derived Trivalent Seasonal Influenza Vaccine Made by the Modified Manufacturing Process With Vaccine Made by the Current Manufacturing Process and a Licensed Trivalent Influenza Vaccine in Healthy Adults Aged 18 Years and Older
Status: Enrolling
Updated: 6/27/2014
Benchmark Research, Austin
mi
from
Austin, TX
Click here to add this to my saved trials
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Randomized, Age-stratified, Double Blind, Controlled Phase 3 Study Comparing a Vero Cell-derived Trivalent Seasonal Influenza Vaccine Made by the Modified Manufacturing Process With Vaccine Made by the Current Manufacturing Process and a Licensed Trivalent Influenza Vaccine in Healthy Adults Aged 18 Years and Older
Status: Enrolling
Updated:  6/27/2014
Jean Brown Research
mi
from
Salt Lake City, UT
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Randomized, Age-stratified, Double Blind, Controlled Phase 3 Study Comparing a Vero Cell-derived Trivalent Seasonal Influenza Vaccine Made by the Modified Manufacturing Process With Vaccine Made by the Current Manufacturing Process and a Licensed Trivalent Influenza Vaccine in Healthy Adults Aged 18 Years and Older
Status: Enrolling
Updated: 6/27/2014
Jean Brown Research
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Randomized, Age-stratified, Double Blind, Controlled Phase 3 Study Comparing a Vero Cell-derived Trivalent Seasonal Influenza Vaccine Made by the Modified Manufacturing Process With Vaccine Made by the Current Manufacturing Process and a Licensed Trivalent Influenza Vaccine in Healthy Adults Aged 18 Years and Older
Status: Enrolling
Updated:  6/27/2014
Anaheim Clinical Trials, LLC
mi
from
Anaheim, CA
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Randomized, Age-stratified, Double Blind, Controlled Phase 3 Study Comparing a Vero Cell-derived Trivalent Seasonal Influenza Vaccine Made by the Modified Manufacturing Process With Vaccine Made by the Current Manufacturing Process and a Licensed Trivalent Influenza Vaccine in Healthy Adults Aged 18 Years and Older
Status: Enrolling
Updated: 6/27/2014
Anaheim Clinical Trials, LLC
mi
from
Anaheim, CA
Click here to add this to my saved trials
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Randomized, Age-stratified, Double Blind, Controlled Phase 3 Study Comparing a Vero Cell-derived Trivalent Seasonal Influenza Vaccine Made by the Modified Manufacturing Process With Vaccine Made by the Current Manufacturing Process and a Licensed Trivalent Influenza Vaccine in Healthy Adults Aged 18 Years and Older
Status: Enrolling
Updated:  6/27/2014
Center for Clinical Trials, LLC.
mi
from
Paramount, CA
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Randomized, Age-stratified, Double Blind, Controlled Phase 3 Study Comparing a Vero Cell-derived Trivalent Seasonal Influenza Vaccine Made by the Modified Manufacturing Process With Vaccine Made by the Current Manufacturing Process and a Licensed Trivalent Influenza Vaccine in Healthy Adults Aged 18 Years and Older
Status: Enrolling
Updated: 6/27/2014
Center for Clinical Trials, LLC.
mi
from
Paramount, CA
Click here to add this to my saved trials
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Randomized, Age-stratified, Double Blind, Controlled Phase 3 Study Comparing a Vero Cell-derived Trivalent Seasonal Influenza Vaccine Made by the Modified Manufacturing Process With Vaccine Made by the Current Manufacturing Process and a Licensed Trivalent Influenza Vaccine in Healthy Adults Aged 18 Years and Older
Status: Enrolling
Updated:  6/27/2014
Clinical Research of South Florida
mi
from
Coral Gables, FL
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Randomized, Age-stratified, Double Blind, Controlled Phase 3 Study Comparing a Vero Cell-derived Trivalent Seasonal Influenza Vaccine Made by the Modified Manufacturing Process With Vaccine Made by the Current Manufacturing Process and a Licensed Trivalent Influenza Vaccine in Healthy Adults Aged 18 Years and Older
Status: Enrolling
Updated: 6/27/2014
Clinical Research of South Florida
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Randomized, Age-stratified, Double Blind, Controlled Phase 3 Study Comparing a Vero Cell-derived Trivalent Seasonal Influenza Vaccine Made by the Modified Manufacturing Process With Vaccine Made by the Current Manufacturing Process and a Licensed Trivalent Influenza Vaccine in Healthy Adults Aged 18 Years and Older
Status: Enrolling
Updated:  6/27/2014
Avail Clinical Research
mi
from
DeLand, FL
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Randomized, Age-stratified, Double Blind, Controlled Phase 3 Study Comparing a Vero Cell-derived Trivalent Seasonal Influenza Vaccine Made by the Modified Manufacturing Process With Vaccine Made by the Current Manufacturing Process and a Licensed Trivalent Influenza Vaccine in Healthy Adults Aged 18 Years and Older
Status: Enrolling
Updated: 6/27/2014
Avail Clinical Research
mi
from
DeLand, FL
Click here to add this to my saved trials